Invention Grant
- Patent Title: Viral vectors for treating Parkinson's disease
-
Application No.: US16318345Application Date: 2017-07-20
-
Publication No.: US11583562B2Publication Date: 2023-02-21
- Inventor: Tyler Lahusen , Charles David Pauza
- Applicant: AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
- Applicant Address: US MD Rockville
- Assignee: AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
- Current Assignee: AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
- Current Assignee Address: US MD Rockville
- Agency: DLA Piper LLP (US)
- International Application: PCT/US2017/043157 WO 20170720
- International Announcement: WO2018/017882 WO 20180125
- Main IPC: A61K35/76
- IPC: A61K35/76 ; A61K31/7105 ; C12N15/113 ; C12N15/86 ; A61K45/06 ; C12N9/10

Abstract:
A lentiviral vector system for expressing a lentiviral particle is disclosed. The lentiviral vector system includes a therapeutic vector, an envelope plasmid, and at least one helper plasmid. The lentiviral vector system can produce a lentiviral particle for inhibiting PARP expression in neuron cells of a subject afflicted with Parkinson's disease.
Public/Granted literature
- US20190282639A1 VIRAL VECTORS FOR TREATING PARKINSON'S DISEASE Public/Granted day:2019-09-19
Information query